Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plant beta-glucans and related non-starch glucans are a diverse group of beta-D-glucose polysaccharides found in the cell walls of cereals (such as oats and barley), fungi, and yeast (Volman et al., 2008). These molecules are characterized by their specific glycosidic linkages, typically beta-(1,3), beta-(1,4), or beta-(1,6), which determine their solubility, viscosity, and biological activity (Wood, 2007). In human health, they primarily function as soluble dietary fibers that provide significant metabolic benefits, including the reduction of LDL cholesterol and the attenuation of postprandial glucose spikes (Tosh, 2013). These effects are largely attributed to the formation of a viscous gel in the small intestine, which slows the rate of nutrient absorption and interferes with bile acid reabsorption (Sima et al., 2018). Furthermore, certain beta-glucans act as biological response modifiers by binding to pattern recognition receptors like Dectin-1 (CLEC7A) on immune cells, thereby stimulating innate immune responses (Brown & Gordon, 2001). Although they are generally classified as nutraceuticals or dietary components rather than classical drug targets, their therapeutic potential is widely utilized in managing cardiovascular disease and as adjuvants in immunotherapy (Goodridge et al., 2009).
Beta-glucans act by increasing the viscosity of the gastrointestinal tract, which slows the absorption of glucose and cholesterol (Tosh, 2013). They also bind to specific receptors such as Dectin-1 (CLEC7A) and Complement Receptor 3 (CR3) on leukocytes, triggering an immune response (Brown & Gordon, 2001). Additionally, they are fermented by gut microbiota into short-chain fatty acids, which contribute to metabolic health (Volman et al., 2008).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plant beta-glucans and related non-starch glucans (Beta-glucan).